PKM
Pyruvate kinase PKM
Also known as: KPYM_HUMAN, OIP3, PK3, PKM2, THBP1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P14618
- Gene
- PKM
- Ensembl
- ENSG00000067225
- Chromosome
- 15
- Canonical length
- 531 aa
- Protein class
- Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Vesicles,Cytosol,Principal piece
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes a protein involved in glycolysis. The encoded protein is a pyruvate kinase that catalyzes the transfer of a phosphoryl group from phosphoenolpyruvate to ADP, generating ATP and pyruvate. This protein has been shown to interact with thyroid hormone and may mediate cellular metabolic effects induced by thyroid hormones. This protein has been found to bind Opa protein, a bacterial outer membrane protein involved in gonococcal adherence to and invasion of human cells, suggesting a role of this protein in bacterial pathogenesis. Several alternatively spliced transcript variants encoding a few distinct isoforms have been reported. [provided by RefSeq, May 2011]
Canonical amino-acid sequenceUniProt
531 residues, UniProt reviewed canonical sequence.
>P14618|PKM
1 MSKPHSEAGT AFIQTQQLHA AMADTFLEHM CRLDIDSPPI TARNTGIICT IGPASRSVET
61 LKEMIKSGMN VARLNFSHGT HEYHAETIKN VRTATESFAS DPILYRPVAV ALDTKGPEIR
121 TGLIKGSGTA EVELKKGATL KITLDNAYME KCDENILWLD YKNICKVVEV GSKIYVDDGL
181 ISLQVKQKGA DFLVTEVENG GSLGSKKGVN LPGAAVDLPA VSEKDIQDLK FGVEQDVDMV
241 FASFIRKASD VHEVRKVLGE KGKNIKIISK IENHEGVRRF DEILEASDGI MVARGDLGIE
301 IPAEKVFLAQ KMMIGRCNRA GKPVICATQM LESMIKKPRP TRAEGSDVAN AVLDGADCIM
361 LSGETAKGDY PLEAVRMQHL IAREAEAAIY HLQLFEELRR LAPITSDPTE ATAVGAVEAS
421 FKCCSGAIIV LTKSGRSAHQ VARYRPRAPI IAVTRNPQTA RQAHLYRGIF PVLCKDPVQE
481 AWAEDVDLRV NFAMNVGKAR GFFKKGDVVI VLTGWRPGSG FTNTMRVVPV PLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PKM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 3,778 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 3,778 nTPM
- tongue: 2,492 nTPM
- choroid plexus: 1,213 nTPM
- retina: 1,155 nTPM
- heart muscle: 633 nTPM
- esophagus: 624 nTPM
Single-cell type
- late spermatids: 3,110 nCPM
- extravillous trophoblasts: 1,864 nCPM
- esophageal suprabasal cells: 1,757 nCPM
- esophageal basal cells: 1,727 nCPM
- platelets: 1,679 nCPM
- esophageal apical cells: 1,307 nCPM
Immune cell
- total PBMC: 1,263 nTPM
- classical monocyte: 837 nTPM
- myeloid DC: 686 nTPM
- intermediate monocyte: 466 nTPM
- non-classical monocyte: 383 nTPM
- T-reg: 334 nTPM
Brain region
- choroid plexus: 1,006 nTPM
- thalamus: 808 nTPM
- medulla oblongata: 733 nTPM
- pons: 724 nTPM
- cerebral cortex: 691 nTPM
- cerebellum: 649 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PKM.
Disease | ImmuneIEDB
Conditions an epitope on PKM was assayed in.
- multiple sclerosis B cell
- allergic disease T cell
ReferencesPubMed · IEDB
Publications for PKM from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- Identification of anti-retinal antibodies in patients with age-related macular degeneration.
2012 · Exp Mol Pathol · RCR 2.2 · 69 citations - Multi-dimensional immunoproteomics coupled with in vitro recapitulation of oncogenic NRASQ61R identifies diagnostically relevant autoantibody biomarkers in thyroid neoplasia.
2019 · Cancer Lett · RCR 0.5 · 13 citations - An unusual pAIR: Anti-PKM2 antibody and occult pancreatic adenocarcinoma.
2024 · Am J Ophthalmol Case Rep
Reference: B cellIEDB
1 publication
- High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.
2016 · Mol Cell Proteomics · RCR 2.5 · 66 citations
Reference: T cellIEDB
1 publication
- Allergen and Epitope Targets of Mouse-Specific T Cell Responses in Allergy and Asthma.
2018 · Front Immunol · RCR 1.1 · 25 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.38
- gnomAD pLI
- 0.85
- gnomAD missense Z
- 2.09
- DepMap mean gene effect
- -0.75
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- canonical glycolysis
- cellular response to insulin stimulus
- glycolytic process
- positive regulation of cytoplasmic translation
- positive regulation of sprouting angiogenesis
- positive regulation of transcription by RNA polymerase II
- programmed cell death
Molecular functions
- ATP binding
- cadherin binding
- histone H3T11 kinase activity
- magnesium ion binding
- MHC class II protein complex binding
- mRNA binding
- non-membrane spanning protein tyrosine kinase activity
- potassium ion binding
- protein homodimerization activity
- protein serine/threonine kinase activity
- protein tyrosine kinase activity
- pyruvate kinase activity
- RNA binding
- transcription coactivator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Pyruvate kinase
- Pyruvate kinase-like, insert domain superfamily
- Pyruvate kinase, barrel
- Pyruvate kinase, C-terminal
- Pyruvate kinase, insert domain superfamily
- Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily
- Pyruvate kinase, active site
- Pyruvate kinase, C-terminal domain superfamily
- Pyruvate kinase-like domain superfamily
- Pyruvate kinase, barrel domain
- Pyruvate kinase, alpha/beta domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PKM in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PKM as an antibody target. Whether an autoantibody or antibody against PKM could matter depends on whether native PKM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PKM is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PKM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...